1. Sanz FJ, Solana-Manrique C, Muñoz-Soriano V, Calap-Quintana P, Moltó MD, Paricio N. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models. Free Radical Biology and Medicine 2017;108:683-91.
2. Rizek P, Kumar N, Jog MS. An update on the diagnosis and treatment of Parkinson disease. The Canadian Medical Association Journal 2016;188(16):1157-65.
3. Elbaz A, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, et al. Risk tables for parkinsonism and Parkinson's disease. Journal of Clinical Epidemiology 2002;55(1):25-31.
4. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Movement disorders: Official Journal of the Movement Disorder Society 2001;16(4):622-30.
5. Lin T-K, Liou C-W, Chen S-D, Chuang Y-C, Tiao M-M, Wang P-W, et al. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson’s disease. Chang Gung Medical Journal 2009;32(6):589-99.
6. Tadibi V, Yosefi B, Taheri H, Taherzadeh J. The impact of a physical therapy regimen on motor function in people with parkinson's disease. J Pajouhesh 2008;18:157-69.
7. Schulze‐Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. European Journal of Biochemistry 1998;254(3):439-59.
8. Wang ZB, Liu YQ, Cui YF. Pathways to caspase activation. Cell Biology International 2005;29(7):489-96.
9. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281(5381):1322-6.
10. Upadhyay D, Panduri V, Ghio A, Kamp DW. Particulate matter induces alveolar epithelial cell DNA damage and apoptosis: role of free radicals and the mitochondria. American Journal of Respiratory Cell and Molecular Biology 2003;29(2):180-7.
11. Marzetti E, Privitera G, Simili V, Wohlgemuth SE, Aulisa L, Pahor M, et al. Multiple pathways to the same end: mechanisms of myonuclear apoptosis in sarcopenia of aging. The Scientific World Journal 2010;10:340-9.
12. Kim S-E, Ko I-G, Kim B-K, Shin M-S, Cho S, Kim C-J, et al. Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus. Experimental Gerontology 2010;45(5):357-65.
13. Bloem B, Irwin I, Buruma O, Haan J, Roos R, Tetrud J, et al. The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. Journal of the Neurological Sciences 1990;97(2-3):273-93.
14. Lev N, Melamed E, Offen D. Apoptosis and Parkinson's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003;27(2):245-50.
15. Roth J, Harré E-M, Rummel C, Gerstberger R, Hubschle T. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Frontiers in Bioscience 2004;9(7):290-300.
16. Yoshigai E, Machida T, Okuyama T, Mori M, Murase H, Yamanishi R, et al. Citrus nobiletin suppresses inducible nitric oxide synthase gene expression in interleukin-1β-treated hepatocytes. Biochemical and Biophysical Research Communications 2013;439(1):54-9.
17. Kimura O, Ohta C, Koga N, Haraguchi K, Kato Y, Endo T. Carrier-mediated uptake of nobiletin, a citrus polymethoxyflavonoid, in human intestinal Caco-2 cells. Food Chemistry 2014;154:145-50.
18. Lee Y-C, Cheng T-H, Lee J-S, Chen J-H, Liao Y-C, Fong Y, et al. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Molecular and Cellular Biochemistry 2011;347(1-2):103-15.
19. Ihara H, Yamamoto H, Ida T, Tsutsuki H, Sakamoto T, Fujita T, et al. Inhibition of nitric oxide production and inducible nitric oxide synthase expression by a polymethoxyflavone from young fruits of Citrus unshiu in rat primary astrocytes. Bioscience, Biotechnology, and Biochemistry 2012:120215.
20. Miyata Y, Tanaka H, Shimada A, Sato T, Ito A, Yamanouchi T, et al. Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin. Life Sciences 2011;88(13-14):613-8.
21. Tominari T, Hirata M, Matsumoto C, Inada M, Miyaura C. Polymethoxy flavonoids, nobiletin and tangeretin, prevent lipopolysaccharide-induced inflammatory bone loss in an experimental model for periodontitis. Journal of Pharmacological Sciences 2012:11188SC.
22. Li W, Wang X, Niu X, Zhang H, He Z, Wang Y, et al. Protective effects of nobiletin against endotoxic shock in mice through inhibiting TNF-α, IL-6, and HMGB1 and regulating NF-κB pathway. Inflammation 2016;39(2):786-97.
23. Parkar N, Bhatt L, Addepalli V. Efficacy of nobiletin, a citrus flavonoid, in the treatment of the cardiovascular dysfunction of diabetes in rats. Food & Function 2016;7(7):3121-9.
24. Zhang L, Zhang X, Zhang C, Bai X, Zhang J, Zhao X, et al. Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo. Brain Research 2016;1636:130-41.
25. Zhang L, Zhao H, Zhang X, Chen L, Zhao X, Bai X, et al. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Research Bulletin 2013;96:45-53.
26. Jeong KH, Jeon M-T, Kim HD, Jung UJ, Jang MC, Chu JW, et al. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease. Journal of Medicinal Food 2015;18(4):409-14.
27. Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience 2014;259:126-41.
28. Bi J, Zhang H, Lu J, Lei W. Nobiletin ameliorates isoflurane-induced cognitive impairment via antioxidant, anti-inflammatory and anti-apoptotic effects in aging rats. Molecular Medicine Reports 2016;14(6):5408-14.
29. Liu L, Wu Xw. Nobiletin protects human retinal pigment epithelial cells from hydrogen peroxide–induced oxidative damage. Journal of Biochemical and Molecular Toxicology 2018;32(5):e22052.
30. Qu Y, Liu Y, Chen L, Zhu Y, Xiao X, Wang D, et al. Nobiletin prevents cadmium-induced neuronal apoptosis by inhibiting reactive oxygen species and modulating JNK/ERK1/2 and Akt/mTOR networks in rats. Neurological Research 2018;40(3):211-20.
31. Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK, et al. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Experimental and Toxicologic Pathology 2015;67(7-8):427-33.
)